Sign in
Username
Password
Lost your password?
Login
Login with Facebook
Login with Google
Login with LinkedIn
(close)
Search for:
Sign in
Register
Country Reports
InFocus
Europe
Asia-Pacific
Americas
Middle East & Africa
Legal & Regulatory
Sign in / Register
Country Reports
Americas
Asia-Pacific
Europe
Middle East & Africa
Vaccines
Legal & Regulatory
Shop
Search for:
Library
Contributions
China
COVID-19
Cell & Gene Therapy
Vaccines
News Releases
Facts & Figures
Directory
Shop
Tagged with HitGen
China: Hitgen Aims to Strengthen its “Innovation Foundation”…
PharmaBoardroom had the pleasure of interviewing HitGen chairman & CEO Dr Jin LI in July regarding the company’s focus on DNA-encoded chemical…
Save
Share
Chinese Biotech Strategies: Biologics or Small Molecules
While the vast majority of the global pharma market still comprises small molecule drugs, the biologics sector has grown rapidly since its inception…
Save
Share
Jin LI – Chairman & CEO, HitGen, China
Dr Jin Li explains Chinese firm HitGen’s unique drug discovery technology platform, how its ability to screen billions of molecules has the…
Save
Share
China Pharma News Roundup May 11th 2020
Top recent news from Chinese pharma, including listings on the Hong Kong Stock Exchange, Junshi's out-licensing of a potential COVID-19 treatment to…
Save
Share
We use cookies to ensure that we give you the best experience on our site. For more info
click here
ACCEPT